首页 | 本学科首页   官方微博 | 高级检索  
     检索      

新型哌啶-查尔酮类衍生物的设计、合成及抗宫颈癌和逆转顺铂耐药活性
引用本文:杨争,吴文平,木合布力.阿布力孜,刘正叶,玉苏普瓦吉木.阿力木江,赛力克阿拉.阿里汗.新型哌啶-查尔酮类衍生物的设计、合成及抗宫颈癌和逆转顺铂耐药活性[J].化学通报,2023,86(9):1126-1136.
作者姓名:杨争  吴文平  木合布力.阿布力孜  刘正叶  玉苏普瓦吉木.阿力木江  赛力克阿拉.阿里汗
作者单位:新疆医科大学 药学院,新疆医科大学 药学院,新疆医科大学 药学院,新疆医科大学 药学院,新疆医科大学 药学院,新疆医科大学 药学院
基金项目:国家自然科学基金项目(82160654,81960625)、新疆维吾尔自治区研究生科研创新项目(XJ2022G168)和新疆天然药物活性组分与释药技术重点实验室资助项目(XJDX1713)资助
摘    要:本文采用活性亚结构拼接原理,设计并合成了15个新型含哌啶的查尔酮类衍生物,利用1H NMR、13C NMR和HR-MS对结构进行表征,并初步评价了其抗宫颈癌和抗顺铂耐药宫颈癌活性作用。结果表明,化合物6g具有一定的抗肿瘤活性和逆转顺铂耐药作用;并采用Elisa法、联合顺铂用药、Western Blot和分子对接对化合物6g与VEGFR-2和P-gp靶点进行了初步的研究。本研究为基于VEGFR-2和P-gp双靶点新型分子靶向查尔酮类衍生物的设计提供了一条思路。

关 键 词:活性亚结构拼接  查尔酮类衍生物  宫颈癌  顺铂耐药宫颈癌  新型分子靶向
收稿时间:2023/1/8 0:00:00
修稿时间:2023/2/20 0:00:00

Design, synthesis and anti-cervical cancer and reversal of cisplatin resistance activity of novel piperidine-chalcone derivatives
yangzheng,WU Wenping,Mourboul Ablise,LIU Zhengye,Yusupuwajimu Alimujiang and Sailikeala Alihan.Design, synthesis and anti-cervical cancer and reversal of cisplatin resistance activity of novel piperidine-chalcone derivatives[J].Chemistry,2023,86(9):1126-1136.
Authors:yangzheng  WU Wenping  Mourboul Ablise  LIU Zhengye  Yusupuwajimu Alimujiang and Sailikeala Alihan
Abstract:In this paper, 15 novel piperidine-containing chalcone derivatives were designed and synthesized using the active substructure splicing principle, and their structures were characterized by 1H-NMR, 13C-NMR and HR-MS, and their anti-cervical cancer and anti-cisplatin-resistant cervical cancer active effects were preliminarily evaluated. The results showed that compound 6g has some antitumor activity and reversal of cisplatin resistance, and preliminary studies of compound 6g with VEGFR-2 and P-gp targets were performed using Elisa assay, co-dosing with cisplatin, Western Blot and molecular docking. This study provides an idea for the design of novel molecularly targeted chalcone derivatives based on the dual targets of VEGFR-2 and P-gp.
Keywords:Glycopyrrolate chalcone  piperidine heterocyclic  cervical cancer  cisplatin resistance  molecular targeting
点击此处可从《化学通报》浏览原始摘要信息
点击此处可从《化学通报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号